Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
Laurine AndreAdeline GalliniFrançois MontastrucNicola ColeyJean-Louis MontastrucBruno VellasSandrine AndrieuVirginie Gardettenull nullPublished in: British journal of clinical pharmacology (2018)
We found no significant association between anticholinergic exposure and cognitive decline in older adults using anticholinergic scales and definitions of exposure.